Unicyte AG

About Unicyte AG

Unicyte AG is a preclinical stage regenerative medicine company with a focus on kidney and liver disorders, diabetes and oncology. Unicyte evolved from a long-term research collaboration of Italy’s University of Turin and Fresenius Medical Care. Unicyte is headquartered in Oberdorf NW, Switzerland, and is an independent affiliate of Fresenius Medical Care, the world's largest provider of products and services for people with chronic kidney failure.
YEAR FOUNDED:
2015
LEADERSHIP:
CEO: Florian Jehle
COO: Daniel Gau
CPO: Ciro Tetta